News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,548 Results
Type
Article (42493)
Company Profile (294)
Press Release (675761)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (210450)
Career Advice (2091)
Deals (36631)
Drug Delivery (107)
Drug Development (83057)
Employer Resources (175)
FDA (16577)
Job Trends (15410)
News (356065)
Policy (33923)
Tag
Academia (2598)
Accelerated approval (5)
Adcomms (21)
Allergies (90)
Alliances (51437)
ALS (92)
Alzheimer's disease (1398)
Antibody-drug conjugate (ADC) (132)
Approvals (16581)
Artificial intelligence (269)
Autoimmune disease (23)
Automation (16)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (111)
Biotechnology (188)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (281)
Cancer (2296)
Cardiovascular disease (183)
Career advice (1752)
Career pathing (31)
CAR-T (153)
Cell therapy (430)
Cervical cancer (19)
Clinical research (67540)
Collaboration (855)
Compensation (539)
Complete response letters (25)
COVID-19 (2661)
CRISPR (46)
C-suite (249)
Cystic fibrosis (103)
Data (2221)
Decentralized trials (2)
Denatured (28)
Depression (46)
Diabetes (274)
Diagnostics (6455)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (111)
Drug shortages (28)
Duchenne muscular dystrophy (94)
Earnings (88332)
Editorial (38)
Employer branding (21)
Employer resources (149)
Events (115283)
Executive appointments (738)
FDA (17860)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (758)
Gene editing (111)
Generative AI (21)
Gene therapy (318)
GLP-1 (749)
Government (4539)
Grass and pollen (5)
Guidances (67)
Healthcare (18998)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (30)
Infectious disease (2804)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (98)
Interviews (322)
IPO (16785)
IRA (47)
Job creations (4057)
Job search strategy (1492)
Kidney cancer (10)
Labor market (38)
Layoffs (490)
Leadership (18)
Legal (8379)
Liver cancer (76)
Lung cancer (322)
Lymphoma (156)
Machine learning (7)
Management (59)
Manufacturing (319)
MASH (69)
Medical device (13464)
Medtech (13469)
Mergers & acquisitions (20386)
Metabolic disorders (709)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (93)
Neuropsychiatric disorders (29)
Neuroscience (1955)
NextGen: Class of 2025 (6637)
Non-profit (4528)
Now hiring (39)
Obesity (379)
Opinion (229)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (239)
Patient recruitment (113)
Peanut (49)
People (59282)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20951)
Phase II (29713)
Phase III (22270)
Pipeline (1216)
Policy (151)
Postmarket research (2654)
Preclinical (8924)
Press Release (68)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (251)
Rare diseases (396)
Real estate (6258)
Recruiting (67)
Regulatory (23145)
Reports (46)
Research institute (2369)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (77)
Series A (133)
Series B (85)
Service/supplier (12)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3726)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (44)
The Weekly (49)
Vaccines (709)
Venture capitalists (41)
Weight loss (253)
Women's health (35)
Worklife (16)
Date
Today (201)
Last 7 days (906)
Last 30 days (2673)
Last 365 days (33290)
2025 (10883)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38616)
2014 (32516)
2013 (27630)
2012 (29730)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (53)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (40726)
Australia (6521)
California (6163)
Canada (2024)
China (539)
Colorado (269)
Connecticut (275)
Delaware (151)
Europe (86954)
Florida (915)
Georgia (206)
Idaho (57)
Illinois (549)
India (26)
Indiana (316)
Iowa (11)
Japan (166)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (903)
Massachusetts (4635)
Michigan (222)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1744)
New Mexico (29)
New York (1756)
North Carolina (987)
North Dakota (8)
Northern California (2691)
Ohio (204)
Oklahoma (14)
Oregon (39)
Pennsylvania (1386)
Puerto Rico (12)
Rhode Island (33)
South America (1162)
South Carolina (23)
South Dakota (1)
Southern California (2312)
Tennessee (101)
Texas (916)
United States (23355)
Utah (182)
Virginia (154)
Washington D.C. (61)
Washington State (559)
West Virginia (3)
Wisconsin (57)
718,548 Results for "collegium pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
April 25, 2025
·
1 min read
Press Releases
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Business
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
Collegium Pharmaceutical, Inc. today announced it has entered into an authorized generic agreement with Hikma Pharmaceuticals USA Inc. (“Hikma”), pursuant to which Hikma will have the exclusive right to sell the authorized generic versions of Nucynta® and Nucynta ® ER.
April 29, 2024
·
4 min read
Press Releases
Collegium to Participate in Upcoming March 2025 Investor Conferences
March 5, 2025
·
1 min read
Press Releases
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
March 17, 2025
·
9 min read
Genetown
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, announced that it has called all $26,350,000 aggregate principal amount of its outstanding 2.625% Convertible Senior Notes Due 2026 for redemption on Friday, June 14, 2024.
April 11, 2024
·
4 min read
Genetown
Collegium to Participate in Jefferies 2024 Global Healthcare Conference
Collegium Pharmaceutical, Inc. announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference being held in New York, NY from June 5-6, 2024.
May 29, 2024
·
1 min read
Press Releases
Collegium Appoints Nancy S. Lurker to its Board of Directors
February 5, 2025
·
5 min read
Business
Collegium Reports First Quarter 2024 Financial Results
Collegium Pharmaceutical, Inc. reported its financial results for the quarter ended March 31, 2024, and provided a corporate update.
May 9, 2024
·
17 min read
Press Releases
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
February 28, 2025
·
21 min read
1 of 71,855
Next
